title: Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic liver disease.
abstract: BACKGROUND
  The aspartate aminotransferases (AST) to platelet ratio index (APRI) may serve as a noninvasive marker to assess liver fibrosis.
  
  
  OBJECTIVE
  To assess the diagnostic ability of the APRI for prediction of fibrosis in patients with chronic hepatitis B (CHB), chronic hepatitis C (CHC), and non-alcoholic fatty liver disease (NAFLD).
  
  
  METHODS
  This retrospective study included 207 patients with CHB, 108 with CHC, and 140 patients with NAFLD. The APRI was calculated as (AST level/upper normal limit for AST)/platelet counts (109/L) × 100. The stage of liver fibrosis in patients with chronic viral hepatitis was graded using the METAVIR scale. The Kleiner system for grading fibrosis was used in patients with NAFLD.
  
  
  RESULTS
  Bivariate correlation analyses showed that the APRI was significantly associated with fibrosis scores in patients with CHC (p = 0.2634, p = 0.0059) and NAFLD (p = 0.2273, p = 0.0069), but not in those with CHB (p = 0.1005, p = 0.1495). Receiver operating characteristic (ROC) curves were used for assessing the ability of the APRI as a predictor of the absence or presence of liver fibrosis (fibrosis score of 0 vs fibrosis scores of 1-4). In patients with CHC, the APRI showed a sensitivity of 72.7% and a specificity of 62.4% for detection of fibrosis (p<0.01). In the NAFLD group, the APRI showed a sensitivity of 60.0% and specificity of 73.3% for detection of fibrosis (p<0.01). In patients with CHB, the APRI showed a sensitivity of 55.0% and a specificity of 75.4% for fibrosis (p=NS).
  
  
  CONCLUSIONS
  The APRI shows an acceptable accuracy for the assessment of liver fibrosis in patients with CHC and NAFLD, but not in those with CHB.
authors.affiliation: Department of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey.
authors.forename: Yusuf
authors.initials: Y
authors.lastname: Yilmaz
authors.forename: Oya
authors.initials: O
authors.lastname: Yonal
authors.forename: Ramazan
authors.initials: R
authors.lastname: Kurt
authors.forename: Muharrem
authors.initials: M
authors.lastname: Bayrak
authors.forename: Bilge
authors.initials: B
authors.lastname: Aktas
authors.forename: Osman
authors.initials: O
authors.lastname: Ozdogan
references.citation: Rev Clin Esp. 2010 Jul-Aug;210(7):317-22
references.pmid: 20466359
references.citation: J Hepatol. 2010 Feb;52(2):160-6
references.pmid: 20034694
references.citation: Trans Am Clin Climatol Assoc. 2009;120:361-8
references.pmid: 19768189
references.citation: Gut Liver. 2007 Dec;1(2):145-50
references.pmid: 20485631
references.citation: Ann Hepatol. 2008 Oct-Dec;7(4):350-7
references.pmid: 19034235
references.citation: Liver Int. 2006 Nov;26(9):1095-9
references.pmid: 17032410
references.citation: Pharmacol Res. 2008 Aug;58(2):129-36
references.pmid: 18652898
references.citation: J Clin Invest. 2005 Feb;115(2):209-18
references.pmid: 15690074
references.citation: Gastroenterol Hepatol. 2010 Jun-Jul;33(6):425-32
references.pmid: 20471720
references.citation: Hepat Mon. 2010 Spring;10(2):88-94
references.pmid: 22312379
references.citation: J Clin Gastroenterol. 2008 Aug;42(7):827-34
references.pmid: 18285716
references.citation: J Hepatol. 2009 Jan;50(1):165-73
references.pmid: 18977552
references.citation: J Gastroenterol Hepatol. 2006 Sep;21(9):1459-65
references.pmid: 16911693
references.citation: Ann Hepatol. 2009 Jan-Mar;8(1):26-31
references.pmid: 19221530
references.citation: Clin Gastroenterol Hepatol. 2009 Feb;7(2):135-40
references.pmid: 19118644
references.citation: Hepatology. 2003 Aug;38(2):518-26
references.pmid: 12883497
references.citation: World J Gastroenterol. 2007 Jan 28;13(4):525-31
references.pmid: 17278217
references.citation: Hepatology. 2005 Jun;41(6):1376-82
references.pmid: 15915455
references.citation: Ann Hepatol. 2009;8 Suppl 1:S4-8
references.pmid: 19381118
references.citation: Expert Rev Gastroenterol Hepatol. 2008 Aug;2(4):541-52
references.pmid: 19072402
references.citation: Hepatology. 2006 Apr;43(4):788-95
references.pmid: 16557548
references.citation: Hepatology. 2005 Jun;41(6):1313-21
references.pmid: 15915461
references.citation: Am J Gastroenterol. 2004 Jun;99(6):1160-74
references.pmid: 15180741
references.citation: Best Pract Res Clin Gastroenterol. 2009;23(3):453-60
references.pmid: 19505671
references.citation: Hepatology. 1996 Aug;24(2):289-93
references.pmid: 8690394
references.citation: HIV Clin Trials. 2008 Jan-Feb;9(1):43-51
references.pmid: 18215981
references.citation: J Ayub Med Coll Abbottabad. 2008 Oct-Dec;20(4):122-6
references.pmid: 19999223
references.citation: Ann Hepatol. 2009;8 Suppl 1:S18-24
references.pmid: 19381120